Frequency of metabolic syndrome in patients of psoriasis

Aisha Ghias, Muhammad Saleem Khan, Eima Shaheen


Objective To find the frequency of metabolic syndrome in patients of psoriasis.


Methods It was an observational study carried out in a tertiary care hospital in Lahore, Pakistan. A total of 100 patients diagnosed as psoriasis both clinically and where needed supplemented by histopathology, were included in the study using non-probability purposive sampling technique. Patients’ data including their body mass index (BMI), waist circumference, systolic and diastolic blood pressure (BP), fasting blood sugar (BSF), fasting triglycerides (FTg) and fasting high density lipoproteins (FHDL) were recorded. Patients were categorized as having metabolic syndrome if their waist circumference was >40cm for males and >35cm for females or their BMI was >30kg/m2 plus they had any two abnormalities among hypertension, raised fasting plasma triglycerides, reduced HDL and raised fasting blood sugar level.


Results There were 73 males and 27 females. Metabolic syndrome was identified in 41 (30 males and 11 females) patients based on International Diabetes Federation consensus worldwide definition. Females were significantly obese than males (p=0.00) and the frequency of females with deranged HDL levels was likewise significantly high as compared to males (p=0.00).


Conclusion Metabolic syndrome is a frequent association in psoriasis patients. Females were obese and had had deranged HDL levels.



Psoriasis, metabolic syndrome

Full Text:



Griffith C, Camp RDR, Barker JNWN. Psoriasis. In: Burns T, Breathnach S, Cox N, Griffith C. editors. Rook’s Textbook of Dermatology. Oxford: Wiley-Blackwell; 2010. P. 20.1.20-28.

Nair RP, Duffin KC, Helms C, Ding J, Stuart PE, Goldgar D. Genome-wide scan reveals association of psoriasis with IL-23 and NF-B pathways. Nature Genet. 2009. Available from: steve_schrodi/40

Wolf N, Quaranta M, Prescott NJ, Allen M. Psoriasis is associated with pleiotropic susceptibility loci identified in type II diabetes and Crohn disease. J Med Genet. 2008;45:114-6.

Chandran V, Raychaudhuri SP. The Geoepidemiology and environmental factors of psoriasis and psoriatic arthritis. J Autoimmun. 2009;34:314-21.

Shai A, Vardy D, Zvulunov A. Psoriasis, biblical afflictions and patients' dignity. Harefuah. 2002;141:479-82.

Love TJ, Qureshi AA, Karlson EW, Gelfand JM. Prevalence of the Metabolic syndrome in psoriasis: Results from the National Health and Nutrition Examination Survey, 2003-2006. Arch Dermatol. 2011;147:419-24.

Bray GA, Clearfield MB, Fintel DJ, Nelinson DS. And obesity: the pathogenesis of cardiometabolic risk. Clin Cornerstone. 2009;9(4):30-40.

Bastard JP, Machi M, Lagathu C, Kim MJ, Caron M, Vidal H et al. Recent advances in the relationship between obesity, inflammation, and insulin resistance. Eur Cytokine Network. 2006;17:4-12.

Malerba M, Gisondi P, Radaeli A. Plasma homocysteine and folate levels in patients with chronic plaque psoriasis. Br J Dermatol. 2006;155:1165-9.

Rodríguez-Zúñiga MJM, García-Perdomo HA. Systemic review and meta-analysis of the association between psoriasis and metabolic syndrome. J Am Acad Dermatol. 2017;77:657-66.

Gami AS, Witt BJ, Howard DE, Erwin PJ, Gami LA, Somers VK et al. Metabolic syndrome and risk of incident cardiovascular events and death: a systematic review and meta-analysis of longitudinal studies. J Am Coll Cardiol. 2007;49:403-14.

Hanley AJ, Karter AJ, Williams K, Festa A, D'Agostino RB, Wagenknecht LE et al. Prediction of type 2 diabetes mellitus with alternative definitions of the metabolic syndrome: the Insulin Resistance Atherosclerosis Study. Circulation. 2005;112:3713-21.

Van Guilder GP, Hoetzer GL, Greiner JJ, Stauffer BL, DeSouza CA. Influence of metabolic syndrome on biomarkers of oxidative stress and inflammation in obese adults. Obesity. 2006;14:2127-31.

de Ferranti SD, Gauvreau K, Ludwig DS, Neufeld EJ, Newburger JW, Rifai N. Prevalence of the metabolic syndrome in American adolescents: findings from the Third National Health and Nutrition Examination Survey. Circulation. 2004;110:2494-7.

Ford ES, Wayne H. Prevalence of the metabolic syndrome among US adults. JAMA. 2002;287:356-9.

Deepa M, Farooq S, Datta M. Prevalence of metabolic syndrome using WHO, ATPIII and IDF definitions in Asian Indians: the Chennai Urban Rural Epidemiology Study (CURES-34). Diabetes Metab Res Rev. 2007;23:127-34.

Gisondi P, Tessari G, Conti A, Piaserico S, Schianchi S, Peserico A et al. Prevalence of metabolic syndrome in patients with psoriasis: a hospital-based case–control study. Br J Dermatol. 2007;157:68-73.

Sommer M, Jenisch S, Suchan M, Christophers E, Weichenthal M. Increased prevalence of the metabolic syndrome in patients with moderate to severe psoriasis. Arch Dermatol Res. 2006;298:321-8.

Nisa N, Qazi MA. Prevalence of metabolic syndrome in patients with psoriasis. Indian J Dermatol Venereol Leprol. 2010;76:662-5.


  • There are currently no refbacks.

ISSN: 1560-9014